Summary
This comes as a major shocker!!!
The EU has initiated formal investigations against a few pharma giants in an Anti Trust Suite.
This is not good for Ranbaxy's European operations.
Ranbaxy is bearly out of the woods with is past troubles, this is going to be a major set back.
Analysis
This comes as a major shocker!!!
The EU has initiated formal investigations against a few pharma giants in an Anti Trust Suite.
This is not good for Ranbaxy European oprations.
Ranbaxy is bearly out of the woods with is past troubles, this is going to be a major set back.
EU has been investigating pharma trade practise for some time now after several complaints from Pro Generic & Anti Generic lobbies.
It seems the Anti Generic lobbies have a upper hand here.
Recent Action of EU investigators is not going to help Ranbaxy's case and an already hammered stock in local markets.
This author consults with leading institutions through GLG
Analyses are solely the work of the authors and have not been edited or endorsed by GLG.
